Literature DB >> 8842487

Biological properties of VEGF/VPF receptors.

B I Terman1, M Dougher-Vermazen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8842487     DOI： 10.1007/bf00437468

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN： 0167-7659            Impact factor:   9.264


× No keyword cloud information.
  41 in total

1.  Interaction of the Flt-1 tyrosine kinase receptor with the p85 subunit of phosphatidylinositol 3-kinase. Mapping of a novel site involved in binding.

Authors:  S A Cunningham; M N Waxham; P M Arrate; T A Brock
Journal:  J Biol Chem       Date:  1995-09-01       Impact factor: 5.157

2.  The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules.

Authors:  H Gitay-Goren; S Soker; I Vlodavsky; G Neufeld
Journal:  J Biol Chem       Date:  1992-03-25       Impact factor: 5.157

3.  High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis.

Authors:  B Millauer; S Wizigmann-Voos; H Schnürch; R Martinez; N P Møller; W Risau; A Ullrich
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

4.  Purification and characterization of a naturally occurring vascular endothelial growth factor.placenta growth factor heterodimer.

Authors:  J DiSalvo; M L Bayne; G Conn; P W Kwok; P G Trivedi; D D Soderman; T M Palisi; K A Sullivan; K A Thomas
Journal:  J Biol Chem       Date:  1995-03-31       Impact factor: 5.157

5.  Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor.

Authors:  D Maglione; V Guerriero; G Viglietto; P Delli-Bovi; M G Persico
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

6.  Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors.

Authors:  S Tessler; P Rockwell; D Hicklin; T Cohen; B Z Levi; L Witte; I R Lemischka; G Neufeld
Journal:  J Biol Chem       Date:  1994-04-29       Impact factor: 5.157

7.  A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF.

Authors:  L Seetharam; N Gotoh; Y Maru; G Neufeld; S Yamaguchi; M Shibuya
Journal:  Oncogene       Date:  1995-01-05       Impact factor: 9.867

8.  Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer.

Authors:  Y Takahashi; Y Kitadai; C D Bucana; K R Cleary; L M Ellis
Journal:  Cancer Res       Date:  1995-09-15       Impact factor: 12.701

9.  VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells.

Authors:  T Cohen; H Gitay-Goren; R Sharon; M Shibuya; R Halaban; B Z Levi; G Neufeld
Journal:  J Biol Chem       Date:  1995-05-12       Impact factor: 5.157

10.  Variations in the size and sulfation of heparin modulate the effect of heparin on the binding of VEGF165 to its receptors.

Authors:  S Soker; D Goldstaub; C M Svahn; I Vlodavsky; B Z Levi; G Neufeld
Journal:  Biochem Biophys Res Commun       Date:  1994-09-15       Impact factor: 3.575
View more
  13 in total

Review 1.  Establishing a link between oncogenes and tumor angiogenesis.

Authors:  R S Kerbel; A Viloria-Petit; F Okada; J Rak
Journal:  Mol Med       Date:  1998-05       Impact factor: 6.354

2.  Oligonucleotide NX1838 inhibits VEGF165-mediated cellular responses in vitro.

Authors:  C Bell; E Lynam; D J Landfair; N Janjic; M E Wiles
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-10       Impact factor: 2.416

Review 3.  The rationale and future potential of angiogenesis inhibitors in neoplasia.

Authors:  G Gasparini
Journal:  Drugs       Date:  1999-07       Impact factor: 9.546

4.  Nimbolide inhibits invasion and migration, and down-regulates uPAR chemokine gene expression, in two breast cancer cell lines.

Authors:  P Elumalai; A Brindha Mercy; R Arunkamar; G Sharmila; F A Bhat; S Balakrishnan; P Raja Singh; J Arunakaran
Journal:  Cell Prolif       Date:  2014-12       Impact factor: 6.831

5.  A vascular gene trap screen defines RasGRP3 as an angiogenesis-regulated gene required for the endothelial response to phorbol esters.

Authors:  David M Roberts; Amanda L Anderson; Michihiro Hidaka; Raymond L Swetenburg; Cam Patterson; William L Stanford; Victoria L Bautch
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

6.  Dihydroartemisinin targets VEGFR2 via the NF-κB pathway in endothelial cells to inhibit angiogenesis.

Authors:  Fengyun Dong; Xia Zhou; Changsheng Li; Suhua Yan; Xianming Deng; Zhiqun Cao; Liqun Li; Bo Tang; Thaddeus D Allen; Ju Liu
Journal:  Cancer Biol Ther       Date:  2014       Impact factor: 4.742

7.  Modulation of angiogenesis by human glioma xenograft models that differentially express vascular endothelial growth factor.

Authors:  J Ma; Z L Fei; A Klein-Szanto; J M Gallo
Journal:  Clin Exp Metastasis       Date:  1998-08       Impact factor: 5.150

Review 8.  Tumor and endothelial cell invasion of basement membranes. The matrigel chemoinvasion assay as a tool for dissecting molecular mechanisms.

Authors:  A Albini
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

9.  The role of vascular actors in two dimensional dialogue of human bone marrow stromal cell and endothelial cell for inducing self-assembled network.

Authors:  Haiyan Li; Richard Daculsi; Maritie Grellier; Reine Bareille; Chantal Bourget; Murielle Remy; Joëlle Amedee
Journal:  PLoS One       Date:  2011-02-03       Impact factor: 3.240

10.  Strength and weakness of phase I to IV trials, with an emphasis on translational aspects.

Authors:  Per Eystein Lønning
Journal:  Breast Cancer Res       Date:  2008-12-18       Impact factor: 6.466
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.